1 Steyn, NP, Mann, J, Bennett, PH, et al. (2004) Diet, nutrition and the prevention of type 2 diabetes. Public Health Nutr 7, 147–165.
2 Schulze, MB & Hu, FB (2005) Primary prevention of diabetes: what can be done and how much can be prevented? Annu Rev Public Health 26, 445–467.
3 Banga, A, Unal, R, Tripathi, P, et al. (2009) Adiponectin translation is increased by the PPARgamma agonists pioglitazone and omega-3 fatty acids. Am J Physiol Endocrinol Metab 296, E480–E489.
4 Vemuri, M, Kelley, DS, Mackey, BE, et al. (2007) Docosahexaenoic Acid (DHA) But Not Eicosapentaenoic Acid (EPA) Prevents Trans-10, Cis-12 Conjugated Linoleic Acid (CLA)-Induced Insulin Resistance in Mice. Metab Syndr Relat Disord 5, 315–322.
5 Itoh, M, Suganami, T, Satoh, N, et al. (2007) Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol 27, 1918–1925.
6 Perez-Matute, P, Perez-Echarri, N, Martinez, JA, et al. (2007) Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-alpha. Br J Nutr 97, 389–398.
7 Oh, DY, Talukdar, S, Bae, EJ, et al. (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687–698.
8 Gonzalez-Periz, A, Horrillo, R, Ferre, N, et al. (2009) Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. Faseb J 23, 1946–1957.
9 Serhan, CN, Chiang, N & Van Dyke, TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8, 349–361.
10 Tanaka, N, Zhang, X, Sugiyama, E, et al. (2010) Eicosapentaenoic acid improves hepatic steatosis independent of PPARalpha activation through inhibition of SREBP-1 maturation in mice. Biochem Pharmacol 80, 1601–1612.
11 Neschen, S, Morino, K, Dong, J, et al. (2007) n-3 Fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator-activated receptor-alpha-dependent manner. Diabetes 56, 1034–1041.
12 Sato, A, Kawano, H, Notsu, T, et al. (2010) Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: importance of hepatic lipogenesis. Diabetes 59, 2495–2504.
13 Jump, DB (2011) Fatty acid regulation of hepatic lipid metabolism. Curr Opin Clin Nutr Metab Care 14, 115–120.
14 Friedberg, CE, Janssen, MJ, Heine, RJ, et al. (1998) Fish oil and glycemic control in diabetes. A meta-analysis. Diabetes Care 21, 494–500.
15 Hartweg, J, Perera, R, Montori, V, et al. (2008) Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst Rev, CD003205.
16 Montori, VM, Farmer, A, Wollan, PC, et al. (2000) Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care 23, 1407–1415.
17 Fedor, D & Kelley, DS (2009) Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care 12, 138–146.
18 Stroup, DF, Berlin, JA, Morton, SC, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283, 2008–2012.
19 Salmeron, J, Hu, FB, Manson, JE, et al. (2001) Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 73, 1019–1026.
20 Schulze, MB, Manson, JE, Willett, WC, et al. (2003) Processed meat intake and incidence of Type 2 diabetes in younger and middle-aged women. Diabetologia 46, 1465–1473.
21 Song, Y, Manson, JE, Buring, JE, et al. (2004) A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: the women's health study. Diabetes Care 27, 2108–2115.
22 Krishnan, S, Coogan, PF, Boggs, DA, et al. (2010) Consumption of restaurant foods and incidence of type 2 diabetes in African American women. Am J Clin Nutr 91, 465–471.
23 Feskens, EJ, Virtanen, SM, Rasanen, L, et al. (1995) Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care 18, 1104–1112.
24 Vessby, B, Aro, A, Skarfors, E, et al. (1994) The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 43, 1353–1357.
25 Colditz, GA, Manson, JE, Stampfer, MJ, et al. (1992) Diet and risk of clinical diabetes in women. Am J Clin Nutr 55, 1018–1023.
26 Harding, AH, Day, NE, Khaw, KT, et al. (2004) Dietary fat and the risk of clinical type 2 diabetes: the European prospective investigation of Cancer-Norfolk study. Am J Epidemiol 159, 73–82.
27 Feskens, EJ, Bowles, CH & Kromhout, D (1991) Inverse association between fish intake and risk of glucose intolerance in normoglycemic elderly men and women. Diabetes Care 14, 935–941.
28 Laaksonen, DE, Lakka, TA, Lakka, HM, et al. (2002) Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet Med 19, 456–464.
29 Brostow, DP, Odegaard, AO, Koh, WP, et al. (2011) Omega-3 fatty acids and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr, .
30 Djousse, L, Biggs, ML, Lemaitre, RN, et al. (2011) Plasma omega-3 fatty acids and incident diabetes in older adults. Am J Clin Nutr 94, 527–533.
31 Djousse, L, Gaziano, JM, Buring, JE, et al. (2011) Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes. Am J Clin Nutr 93, 143–150.
32 Hodge, AM, English, DR, O'Dea, K, et al. (2007) Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr 86, 189–197.
33 Kaushik, M, Mozaffarian, D, Spiegelman, D, et al. (2009) Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus. Am J Clin Nutr 90, 613–620.
34 Krachler, B, Norberg, M, Eriksson, JW, et al. (2008) Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 18, 503–510.
35 Kroger, J, Zietemann, V, Enzenbach, C, et al. (2011) Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 93, 127–142.
36 Meyer, KA, Kushi, LH, Jacobs, DR Jr, et al. (2001) Dietary fat and incidence of type 2 diabetes in older Iowa women. Diabetes Care 24, 1528–1535.
37 Nanri, A, Mizoue, T, Noda, M, et al. (2011) Fish intake and type 2 diabetes in Japanese men and women: the Japan Public Health Center-based Prospective Study. Am J Clin Nutr 94, 884–891.
38 Patel, PS, Sharp, SJ, Jansen, E, et al. (2010) Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. Am J Clin Nutr 92, 1214–1222.
39 Patel, PS, Sharp, SJ, Luben, RN, et al. (2009) Association between type of dietary fish and seafood intake and the risk of incident type 2 diabetes: the European prospective investigation of cancer (EPIC)-Norfolk cohort study. Diabetes Care 32, 1857–1863.
40 van Dam, RM, Willett, WC, Rimm, EB, et al. (2002) Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 25, 417–424.
41 van Woudenbergh, GJ, van Ballegooijen, AJ, Kuijsten, A, et al. (2009) Eating fish and risk of type 2 diabetes: A population-based, prospective follow-up study. Diabetes Care 32, 2021–2026.
42 Vang, A, Singh, PN, Lee, JW, et al. (2008) Meats, processed meats, obesity, weight gain and occurrence of diabetes among adults: findings from Adventist Health Studies. Ann Nutr Metab 52, 96–104.
43 Villegas, R, Xiang, YB, Elasy, T, et al. (2011) Fish, shellfish, and long-chain n-3 fatty acid consumption and risk of incident type 2 diabetes in middle-aged Chinese men and women. Am J Clin Nutr 94, 543–551.
44 Wang, L, Folsom, AR, Zheng, ZJ, et al. (2003) Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 78, 91–98.
45 Micha, R, Wallace, SK & Mozaffarian, D (2010) Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation 121, 2271–2283.
46 Greenland, S & Longnecker, MP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135, 1301–1309.
47 Orsini, N, Bellocco, R & Greenland, S (2006) Generalized least squares for trend estimation of summarized dose-response data. Stata Journal 6, 40–57.
48 Micha, R, Kalantarian, S, Wirojratana, P, et al. (2011) Estimating the global and regional burden of suboptimal nutrition on chronic disease: methods and inputs to the analysis. Eur J Clin Nutr.
49 Higgins, JP, Thompson, SG, Deeks, JJ, et al. (2003) Measuring inconsistency in meta-analyses. BMJ 327, 557–560.
50 Begg, CB & Mazumdar, M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088–1101.
51 Griffin, MD, Sanders, TA, Davies, IG, et al. (2006) Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45–70 y: the OPTILIP Study. Am J Clin Nutr 84, 1290–1298.
52 Giacco, R, Cuomo, V, Vessby, B, et al. (2007) Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids? Nutr Metab Cardiovasc Dis 17, 572–580.
53 Egert, S, Fobker, M, Andersen, G, et al. (2008) Effects of dietary alpha-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid on parameters of glucose metabolism in healthy volunteers. Ann Nutr Metab 53, 182–187.
54 Chiu, M, Austin, PC, Manuel, DG, et al. (2011) Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care 34, 1741–1748.
55 Wildman, RP, Gu, D, Reynolds, K, et al. (2004) Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among Chinese adults. Am J Clin Nutr 80, 1129–1136.
56 Mozaffarian, D & Wu, JH (2011) Omega-3 Fatty Acids and Cardiovascular Disease – Effects on Risk Factors, Molecular Pathways, and Clinical Events. J Am Coll Cardiol 58, 2047–2067.
57 Ghafoorunissa, , Ibrahim, A & Natarajan, S (2005) Substituting dietary linoleic acid with alpha-linolenic acid improves insulin sensitivity in sucrose fed rats. Biochim Biophys Acta 1733, 67–75.
58 Mustad, VA, Demichele, S, Huang, YS, et al. (2006) Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse. Metabolism 55, 1365–1374.
59 Kelley, DS, Vemuri, M, Adkins, Y, et al. (2009) Flaxseed oil prevents trans-10, cis-12-conjugated linoleic acid-induced insulin resistance in mice. Br J Nutr 101, 701–708.
60 Wendland, E, Farmer, A, Glasziou, P, et al. (2006) Effect of alpha linolenic acid on cardiovascular risk markers: a systematic review. Heart 92, 166–169.
61 Bloedon, LT, Balikai, S, Chittams, J, et al. (2008) Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr 27, 65–74.